Adc Therapeutics Sa · NYSE:ADCT
RedCo II Master Fund, L.P. sold 5,880,415 Adc Therapeutics Sa shares (Form 4)
Traded Mar 31 to Apr 2, 2026 · Filed Apr 2, 2026
From Mar 31 to Apr 2, 2026, RedCo II Master Fund, L.P. (10% owner) sold 5,880,415 Adc Therapeutics Sa shares at an average US$3.34 for US$19.6M, leaving 10,265,297 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 5,880,415 shares
- Price
- US$3.34 average (US$3.28 to US$3.80)
- Value
- US$19.6M
- Holding after
- 10,265,297 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Sale | 196,229 | US$3.75 | 15,470,502 | Indirect |
| Mar 31, 2026 | Common Stock | Sale | 188,407 | US$3.75 | 12,957,305 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 169,265 | US$3.80 | 15,301,237 | Indirect |
| Apr 1, 2026 | Common Stock | Sale | 162,517 | US$3.80 | 12,794,788 | Direct |
| Apr 2, 2026 | Common Stock | Sale | 2,634,506 | US$3.28 | 12,666,731 | Indirect |
| Apr 2, 2026 | Common Stock | Sale | 2,529,491 | US$3.28 | 10,265,297 | Direct |